NL193191B - 1,3-Oxazolidine-2-on-derivaten en farmaceutisch preparaat dat een dergelijke verbinding bevat. - Google Patents

1,3-Oxazolidine-2-on-derivaten en farmaceutisch preparaat dat een dergelijke verbinding bevat.

Info

Publication number
NL193191B
NL193191B NL8501579A NL8501579A NL193191B NL 193191 B NL193191 B NL 193191B NL 8501579 A NL8501579 A NL 8501579A NL 8501579 A NL8501579 A NL 8501579A NL 193191 B NL193191 B NL 193191B
Authority
NL
Netherlands
Prior art keywords
oxazolidine
derivatives
compound
pharmaceutical composition
composition containing
Prior art date
Application number
NL8501579A
Other languages
English (en)
Other versions
NL8501579A (nl
NL193191C (nl
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of NL8501579A publication Critical patent/NL8501579A/nl
Publication of NL193191B publication Critical patent/NL193191B/nl
Application granted granted Critical
Publication of NL193191C publication Critical patent/NL193191C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL8501579A 1984-09-28 1985-05-31 1,3-Oxazolidine-2-on-derivaten en farmaceutisch preparaat dat een dergelijke verbinding bevat. NL193191C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20362484 1984-09-28
JP59203624A JPS6183170A (ja) 1984-09-28 1984-09-28 新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法

Publications (3)

Publication Number Publication Date
NL8501579A NL8501579A (nl) 1986-04-16
NL193191B true NL193191B (nl) 1998-10-01
NL193191C NL193191C (nl) 1999-02-02

Family

ID=16477122

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8501579A NL193191C (nl) 1984-09-28 1985-05-31 1,3-Oxazolidine-2-on-derivaten en farmaceutisch preparaat dat een dergelijke verbinding bevat.

Country Status (27)

Country Link
US (1) US4644063A (nl)
JP (1) JPS6183170A (nl)
KR (1) KR900004323B1 (nl)
AR (1) AR240924A1 (nl)
AT (1) AT392069B (nl)
AU (1) AU566419B2 (nl)
BR (1) BR8502707A (nl)
CA (1) CA1252092A (nl)
CH (1) CH663207A5 (nl)
CS (1) CS273606B2 (nl)
DE (1) DE3519261C2 (nl)
DK (1) DK165952C (nl)
ES (2) ES8800571A1 (nl)
FR (1) FR2571052B1 (nl)
GB (2) GB8512975D0 (nl)
HU (1) HU199132B (nl)
IN (1) IN162060B (nl)
IT (1) IT1208807B (nl)
MX (2) MX161397A (nl)
MY (1) MY102081A (nl)
NL (1) NL193191C (nl)
NZ (1) NZ212143A (nl)
PH (1) PH20852A (nl)
RO (1) RO91422B (nl)
SE (1) SE463100B (nl)
SU (2) SU1402263A3 (nl)
ZA (1) ZA854001B (nl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6183147A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤
JPH0759570B2 (ja) * 1986-05-06 1995-06-28 三井東圧化学株式会社 ２−オキサゾリジノン類の製造方法
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
DE3877470T2 (de) * 1987-09-10 1993-06-24 Merck Sharp & Dohme Oxazole und thiazole zur behandlung seniler demenz.
DE68915595T2 (de) * 1988-03-24 1994-09-15 Sankyo Co Verwendung von Isoxazolinonen als cerebro-aktive Medikamente.
JPH0314562A (ja) * 1988-04-11 1991-01-23 Nippon Chemiphar Co Ltd 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
DE69320730T2 (de) * 1992-07-14 1999-02-11 Nippon Chemiphar Co. Ltd., Tokio/Tokyo Alkylendiaminderivate
NZ314207A (en) * 1992-09-28 2000-12-22 Vertex Pharma 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
ES2111326T3 (es) * 1993-09-15 1998-03-01 Merck Sharp & Dohme Derivados de imidazolona y oxazolona como antagonistas de dopamina.
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
US6037354A (en) 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
BR112015021940A2 (pt) 2013-03-14 2017-07-18 Akzo Nobel Chemicals Int Bv composição agrícola que compreende pelo menos uma substância química agrícola e pelo menos um éter de celulose; método de redução do desvio de pulverização durante a pulverização de uma solução aquosa; e método de aumento da resistência à lavagem pela chuva de uma solução aquosa pulverizada sobre uma superfície

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437389A (en) * 1948-03-09 Oxazoeidones and erocesstok
DE1135461B (de) * 1959-05-08 1962-08-30 Knoll Ag Verfahren zur Herstellung von basisch substituierten Phthalimidinen
FR1301267A (fr) * 1961-04-04 1962-08-17 Science Union Et Compagnie Soc Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation
US3131197A (en) * 1963-03-13 1964-04-28 Smith Kline French Lab 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
FR2179582B1 (nl) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
BR8502707A (pt) 1986-05-27
SE8502525L (sv) 1986-03-29
CH663207A5 (fr) 1987-11-30
HU199132B (en) 1990-01-29
PH20852A (en) 1987-05-19
DK230185D0 (da) 1985-05-23
KR900004323B1 (ko) 1990-06-22
SE463100B (sv) 1990-10-08
IT1208807B (it) 1989-07-10
DK165952C (da) 1993-07-05
MY102081A (en) 1992-03-31
GB8513685D0 (en) 1985-07-03
NZ212143A (en) 1987-11-27
GB8512975D0 (en) 1985-06-26
ES8802152A1 (es) 1988-04-01
CS392785A2 (en) 1990-08-14
DE3519261C2 (de) 1997-01-16
MX21592A (es) 1994-01-31
SU1402263A3 (ru) 1988-06-07
CS273606B2 (en) 1991-03-12
GB2165237B (en) 1987-12-09
KR860002502A (ko) 1986-04-26
RO91422A (ro) 1987-06-30
NL8501579A (nl) 1986-04-16
JPH0469150B2 (nl) 1992-11-05
FR2571052A1 (fr) 1986-04-04
AU4469785A (en) 1986-04-10
MX161397A (es) 1990-09-20
AR240924A1 (es) 1991-03-27
DK230185A (da) 1986-03-29
JPS6183170A (ja) 1986-04-26
ES543517A0 (es) 1987-11-01
GB2165237A (en) 1986-04-09
ES557075A0 (es) 1988-04-01
IN162060B (nl) 1988-03-19
DK165952B (da) 1993-02-15
ZA854001B (en) 1986-01-29
AU566419B2 (en) 1987-10-22
RO91422B (ro) 1987-07-02
SE8502525D0 (sv) 1985-05-22
AR240924A2 (es) 1991-03-27
FR2571052B1 (fr) 1988-03-04
ES8800571A1 (es) 1987-11-01
SU1431679A3 (ru) 1988-10-15
US4644063A (en) 1987-02-17
AT392069B (de) 1991-01-25
IT8567500A0 (it) 1985-05-30
HUT39168A (en) 1986-08-28
CA1252092A (en) 1989-04-04
ATA165685A (de) 1990-07-15
DE3519261A1 (de) 1986-04-10
NL193191C (nl) 1999-02-02

Similar Documents

Publication Publication Date Title
NL193457B (nl) Benzoheterocyclische verbindingen en farmaceutisch preparaat dat een dergelijke verbinding bevat.
DE68914619D1 (de) Verabreichungssystem für eine zusammensetzung.
NL191540C (nl) Verbinding met antihypercholesteremische werkzaamheid, alsmede farmaceutisch preparaat dat deze verbinding bevat.
NL193024B (nl) Piperazinederivaten en farmaceutisch preparaat dat een dergelijk piperazinederivaat bevat.
DE3669876D1 (de) 3,4-dihydrobenzopyranderivate.
DE3669132D1 (de) Bandumreifungsmaschine.
NL192832B (nl) 1,8 gebrugde 6-halogeen-4-chinolon-3-carbonzuurderivaten en farmaceutisch preparaat dat een dergelijk derivaat bevat.
NL193022B (nl) N-acyl-alfa-amino-alfa,omega-alkaandicarbonzuuramiden en farmaceutisch preparaat dat een dergelijke verbinding bevat.
DK83485D0 (da) Laegemiddel indeholdende kvartaere 3,4-dihydroisochinoliniumsalte
FI851234L (fi) Substituerade -aminosyror, deras framstaellning samt farmaceutiska kompositioner innehaollande dessa.
FI852868A7 (fi) Jodoforikoostumus.
FI902315A0 (fi) Foerfarande foer framstaellning av piperidylidendihydrodibenso/a,d/cykloheptener och deras azaderivat, foereningar framstaellda enligt detta foerfarande och anvaendning av dessa foereningar foer framstaellning av nyttiga farmaceutiska kompositioner.
GB2165237B (en) 1,3-oxazolidine-2-one derivatives
DE3576138D1 (de) Verpackungsmaschine.
IT1213453B (it) Composizione farmaceutica.
FI872553A7 (fi) Paikallisesti käytettävien lääkeaineiden väliaine.
FI852647A7 (fi) 3-aminokarbonyylimetoksi-5 -fenyylipyratsoliyhdisteet ja niiden valmistusmenetelmä sekä näitä yhdisteitä sisältävät lääkeaineet.
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
FI851134A0 (fi) Farmaceutisk komposition, som innehaoller tetracyklin- eller doxicyklinsalter och foerfarande foer framstaellning av en saodan komposition.
FI853866A7 (fi) 2-pyridiini-tioli-johdannaiset, menetelmäniiden valmistamiseksi ja niitä sisältävät farmaseuttiset yhdisteet.
DE3586745D1 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
FI860449A0 (fi) Komposition foer behandling av graesmatta.
FI861951A7 (fi) 1,3-oxatianderivat.
DK437685D0 (da) 1alfa,25-dihydroxy-22z-dehydrovitamin d forbindelser
DE58905106D1 (de) Neue 1,2-dithiol-3-thion-s-oxid-verbindungen enthaltende arzneimittel.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 20001201